Optimising time-in-target-range assessment for blood pressure: insights from a large-scale study with continual cuffless monitoring

Last reviewed:
26 Jun 2024,
Author:

This study examines blood pressure (BP) time-in-target-range (TTR) as a cardiovascular risk predictor. Analysing 2.3 million readings from 5,189 European users with a cuffless BP monitor, it found that traditional measurement schedules often misclassified risk levels. Accurate TTR assessment requires continuous 24-hour monitoring over 7 days, suggesting that frequent, prolonged BP measurement is essential for effective hypertension management.

Link to publication: New Frontier

Traditional blood pressure cuff vs. Aktiia

Cuff

Aktiia
Meets ISO81060-2 Standard
Day-Time Blood Pressure
Average 70+
measurements a week
Night-Time Blood Pressure
Automatic Measurements

About the Author

Josep Solà is a renowned innovator, scientist, and pioneer in the field of blood pressure technology. He has been dedicated to revolutionising hypertension care and enhancing patient outcomes since 2004.
Armed with a Ph.D. (Doctor of Science) degree from ETH Zurich, Solà currently serves as the Co-Founder and Chief Technology Officer (CTO) of Aktiia.

Try Aktiia for yourself

Gain access to these benefits with the Aktiia solution.

Shop Now

Stay updated

Join our mailing list for the latest developments.

Your Basket
Your basket is emptyReturn to Shop
Calculate Shipping